- Home
- SBH vs CRVS Comparison
SBH vs CRVS Comparison
Compare SBH & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBH | CRVS |
|---|---|---|
| Founded | 1964 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2006 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SBH | CRVS |
|---|---|---|
| Price | $15.13 | $14.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | $17.25 | ★ $30.17 |
| AVG Volume (30 Days) | ★ 1.5M | 1.5M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 32.17 | ★ 48.04 |
| EPS | ★ 0.88 | N/A |
| Revenue | ★ $3,701,424,000.00 | N/A |
| Revenue This Year | $2.20 | N/A |
| Revenue Next Year | $1.82 | N/A |
| P/E Ratio | $16.88 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.37 | $3.96 |
| 52 Week High | $17.92 | $26.95 |
Technical Indicators
Market Signals| Indicator | SBH | CRVS |
|---|---|---|
| Relative Strength Index (RSI) | 58.54 | 51.82 |
| Support Level | $13.85 | $14.24 |
| Resistance Level | $15.65 | $16.66 |
| Average True Range (ATR) | 0.56 | 0.83 |
| MACD | 0.02 | -0.09 |
| Stochastic Oscillator | 62.65 | 21.40 |
Price Performance
Historical ComparisonAbout SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. The company operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, Netherlands, and other geographical regions. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. The products offered by the company include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.